Children's National Medical Center/George Washington University Medical School

111 Michigan Avenue, NW, Suite W 3.5-100
Washington
DC
20010
USA
Contact Person: Bernhard L. Wiedermann, MD, MA
Phone: (202) 476-5051
Fax: (202) 476-3850

TRAINING PROGRAM DIRECTOR: Bernhard L. Wiedermann, MD, MA
RESEARCH INTERESTS: Medical education, educational technology, telemedicine, evidence-based medicine, transplant infectious diseases

TRAINING PROGRAM CO-DIRECTOR: Nada Harik, MD
RESEARCH INTERESTS: staphylococcus aureus epidemiology and pathogenesis, osteomyelitis/septic arthritis, infections in children with cystic fibrosis, infection prevention and quality improvement, tick borne infections, medical student/resident/fellow education, and pediatric tuberculosis

CHIEF OF INFECTIOUS DISEASES: Roberta DeBiasi, MD, MS 
RESEARCH INTERESTS: intrauterine and perinatal viral infections, including Zika virus, antiviral therapy, Lyme disease, Kawasaki disease

ASSOCIATES/DIVISION MEMBERS

FACULTY: Joseph Campos, PhD
RESEARCH INTEREST:Clinical Microbiology, Bioinformatics, Molecular Diagnostics

FACULTY: Kathy Ferrer, MD
RESEARCH INTEREST:Adherence and Disclosure in children and adolescents with perinatally acquired HIV infection, Global pediatric HIV infection

FACULTY:Andrea Hahn, MD
RESEARCH INTEREST: airway microbiome and antimicrobial resistance in children with cystic fibrosis

FACULTY: Rana Hamdy, MD, MPH
RESEARCH INTEREST: antimicrobial stewardship, antimicrobial-resistant infections

FACULTY:Benjamin Hanisch, MD
RESEARCH INTEREST: Pediatric transplant infectious diseases, tropical infectious diseases

FACULTY: Barbara Jantausch, MD
RESEARCH INTEREST:Microbial pathogenesis, UTI, pneumococcal infections, antimicrobial therapeutics

FACULTY: Natella Rakhmanina, MD, PhD, AAHIVS
RESEARCH INTEREST:HIV Pharmacology, pharmacogenetics of antiretroviral drugs

FACULTY: Xiaoyan Song, PhD, MSc
RESEARCH INTEREST:Epidemiology, Biostatistics

FDA FACULTY: Sumathi Nambiar, MD
RESEARCH INTEREST:FDA CDER, Anti-infective Agents and Regulatory Issues

FDA FACULTY: Prabha Viswanathan, MD
RESEARCH INTEREST:FDA CDER, Anti-infective Agents and Regulatory Issues

FDA FACULTY: Wellington Sun, MD
RESEARCH INTEREST: FDA CBER, Vaccines, Devices and Regulatory Issues

FDA FACULTY: Doran Fink, MD, PhD
RESEARCH INTEREST:FDA CBER, Vaccines, Devices and Regulatory Issues


TITLE(S) OF RECENT FELLOWS’ PUBLISHED PAPERS OR RESEARCH PROJECTS:
FDA Track fellows’ regulatory research projects are published on the FDA website.

AlarconAE, Jantausch B. Listeriosis. In In Kline MD, ed. Rudolph’s Pediatrics, 23rd edition, McGraw-Hill Education, New York, in press.

Alarcon AE, Wiedermann BL. Relapsing fever. In Kline MD, ed. Rudolph’s Pediatrics, 23rd edition, McGraw-Hill Education, New York, in press.

Appiah GD, Kao GF, Kao WH, DeBiasi RL. A 14-year-old boy with nodules on his feet. J Pediatr Infect Dis Soc 2014; 3:265-266.

Del Castillo M. Chancroid. In Kline MD, ed. Rudolph’s Pediatrics, 23rd edition, McGraw-Hill Education, New York, in press.

Del Castillo M. Gonorrhea. In Kline MD, ed. Rudolph’s Pediatrics, 23rd edition, McGraw-Hill Education, New York, in press.

Dubrocq G. Mycoplasma. In Kline MD, ed. Rudolph’s Pediatrics, 23rd edition, McGraw-Hill Education, New York, in press.

Dubrocq G., Hanisch B. Campylobacter. In Kline MD, ed. Rudolph’s Pediatrics, 23rd edition, McGraw-Hill Education, New York, in press.

Dubrocq G, Rakhmanina N, Phelps BR. Challenges and Opportunities in the Development of HIV Medications in Pediatric Patients. Paediatric drugs. 2017; 1 : 4.

Dubrocq G, Needles, M, Jantausch B. Recurrent Fever and Mouth Ulcers in a Healthy Child. J Pediatr Infect Dis Soc 2017; 6:e155-157.

Dubrocq G, Wang K, Spaeder MC, Hahn A. Septic Shock Secondary to Chikungunya Virus in a 3-Month-Old Traveler Returning From Honduras. J Pediatr Infect Dis Soc 2017; 6:e158-160.

Kumar, M. Meningococcus. In Kline MD, ed. Rudolph’s Pediatrics, 23rd edition, McGraw-Hill Education, New York, in press.

Kumar M. Leptospirosis In Kline MD, ed. Rudolph’s Pediatrics, 23rd edition, McGraw-Hill Education, New York, in press.

Kumar M, Jantausch B, Torres C, Campos J, Zelazny A. Central Line-Associated Mucor velutinosus Bloodstream Infection in an Immunocompetent Pediatric Patient. J Pediatr Infect Dis Soc, in press.

Needles Enterococcus. In Kline MD, ed. Rudolph’s Pediatrics, 23rd edition, McGraw-Hill Education, New York, in press.

Purandare A, Jantausch B. Parvovirus. In: Read JS, Schleiss MR, ed. Congenital & Perinatal Infections. NY: Oxford University Press; 2017: 157-165.

Purandare A. Syphilis. In Kline MD, ed. Rudolph’s Pediatrics, 23rd edition, McGraw-Hill Education, New York, in press.

Purandare A. Tetanus. In Kline MD, ed. Rudolph’s Pediatrics, 23rd edition, McGraw-Hill Education, New York, in press.


MAJOR FEATURES OF TRAINING PROGRAM:

Our program consists of three tracks: two are FDA Tracks affiliated with the United States Food and Drug Administration, and the third is a Traditional Track. Clinical training is identical for all three tracks, with the tracks differing in research training focus.

Clinical training at CNMC consists of approximately 9 months inpatient and 3 months outpatient total experience over the 3-year program. Fellows will have dedicated experiences on the general infectious diseases inpatient consult service, a combined inpatient and outpatient transplant infectious diseases and primary immunodeficiency service, and a general infectious diseases outpatient service. Clinical training in pediatric infectious diseases is similar for the combined medicine-pediatrics ID fellowship.

Fellows may pursue a wide variety of opportunities for research training in clinical, basic science, epidemiologic and outcomes research. Research training for the Traditional Track can be performed either at CNMC, GWU, or at the National Institutes of Allergy and Infectious Diseases at NIH, depending on the fellow’s research interests. Other arrangements can be made for special circumstances. For the FDA Tracks, the primary scholarly product for the American Board of Pediatrics certification is a major review of an antibiotic, antiviral, vaccine, or biologic agent undergoing review as a new product or for a new indication. FDA fellows also will engage in clinical and/or health quality research. All fellows may pursue formal degree work, including MPH and MS degrees, through the George Washington University if desired.

In addition to our pediatric infectious diseases fellowship, we also sponsor a 4-year combined internal medicine-pediatrics infectious diseases fellowship program, in partnership with the National Institute of Allergy and Infectious Diseases (NIAID). This program consists of 2 years of clinical infectious diseases (1 pediatric, 1 adult medicine) and 2 years of research at NIAID and/or CNMC and is open to individuals who have completed a combined internal medicine-pediatrics residency program.


AFFILIATED HOSPITALS: Children's National Medical Center
(also NIH Clinical Center for Med-Peds ID fellows)

NUMBER OF PEDIATRIC BEDS: 323 

FELLOWS ACCEPTED EACH YEAR: 1 for each of the 3 tracks; med-peds numbers vary 

TRAINING FOR: MD; DO; MD, PhD

FUNDING IS ENSURED FOR ALL 3 YEARS: Yes 

VISAS ACCEPTED: J1, H1B (FDA tracks must be US citizens or green card holders per federal regulations)

IS COMPLETION OF PEDIATRIC RESIDENCY TRAINING IN THE U.S. OR CANADA A REQUIREMENT? Yes

THE PROGRAM OFFERS THE FOLLOWING TRAINING:

Program provides training in diagnostic microbiology using laboratories on site:

Microbiology laboratory: YES
Clinical virus isolation laboratory: YES
Molecular diagnostics: YES

Program provides training in infection control and hospital epidemiology as:

Didactic lectures: YES
Hands on experience: YES
Infection Control Meetings/Membership: VARIES

Opportunity to fulfill the ABP requirements for scholarly activity is available in the following general areas:

  • Bacteriology/bacterial infections 
  • Epidemiology and statistics
  • Infection control/hospital epidemiology
  • Immunizations/Public health
  • Mycology/fungal infections
  • Parasitology/parasitic diseases
  • Virology/viral diseases
  • Antimicrobial agents
  • Antibiotic/antiviral/vaccine/biologic

Research opportunities in the section’s program could be described as:

  • Basic (bench)
  • Molecular
  • Community
  • Epidemiologic
  • Clinical
  • International/Public Health
  • Health Services
  • HIV, Basic
  • ACTG Site

Documented liaison exists offering opportunities for research experience n the laboratory of investigator(s) who is (are) not faculty of the section: YES

Program offers the opportunity to obtain a Master’s degree in a field such as Public Health, Education, Clinical Sciences, or Epidemiology (assuming appropriate arrangements are made): YES

Graduate school courses are available to trainee (assuming appropriate arrangements are made): YES

Program provides substantial clinical experiences for trainees in special areas/hosts:

  • HIV
  • Bone marrow transplantation
  • Solid organ/transplantation
  • travelers/adoptees
  • Adults
  • Congenital immune deficiencies

Program includes ABP-required core curricula in scholarly activities in didactic lecture course for fellows (includes epidemiology, statistics, research design, and academic careers): YES

Program has an NIH-sponsored training grant: NO

The Infectious Diseases Service is the primary care provider for HIV-infected children and adolescents: NO

Average number of new outpatient consultations per month: Approx 175 total visits (new and follow up) per month

Average number of new inpatient consultations per month: Approx 485 total visits (new and follow up) per month

Number of trainees completing program in the last 5 years: 10